Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 1/20 | 0.37 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3861184 | 0.91 | NFE2L2 (0.33) | MCHR1IRAK4CA1CA2CA7 | |
| SCHEMBL16961106 | 0.89 | NFE2L2 (0.45) | ALDH1A1MEN1KMT2ANFE2L2MAPT | |
| SCHEMBL6365322 | 0.89 | NFE2L2 (0.44) | ALDH1A1MEN1KMT2ANFE2L2MAPT | |
| SCHEMBL16953917 | 0.85 | GSK3A (0.38) | MCHR1IRAK4ALDH1A1ACHEMEN1 | |
| SCHEMBL7194918 | 0.85 | NFE2L2 (0.45) | MCHR1IRAK4CA1CA2CA7 | |
| SCHEMBL16960343 | 0.84 | KCNK3 (0.40) | MCHR1IRAK4CA1CA2CA7 | |
| SCHEMBL677042 | 0.83 | MCHR1 (0.38) | MCHR1IRAK4CA1CA2CA7 | |
| SCHEMBL14843107 | 0.83 | MAPT (0.33) | IRAK4ALDH1A1MAPTLMNASMN1; SMN2 | |
| SCHEMBL419697 | 0.82 | ALDH1A1 (0.43) | MCHR1IRAK4ALDH1A1ACHEMEN1 | |
| SCHEMBL22476163 | 0.81 | SCN4A (0.38) | ALDH1A1LMNACYP1A2CYP2C9CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108201934-B | Stone grinding device for engineering and working method thereof | XUZHOU INSTITUTE OF TECHNOLOGY (CN) | 2019-12-10 | — | — | CN | disclosed |
| EP-1371657-A1 | Transition-metal complexes and use thereof in transition-metal catalysed reactions.. | Bayer Aktiengesellschaft (DE) | 2003-12-17 | — | — | EP | disclosed |
| US-20030220512-A1 | Novel transition metal complexes and their use in transition metal-catalysed reactions | BAYER AKTIENGESELLSCHAFT (DE) | 2003-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220512-A1 | Novel transition metal complexes and their use in transition metal-catalysed reactions | AP1M1, AP3M1, CYC1 | MCHR1 2498/4885IRAK4 4025/4885CA1 327/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.